Drug Utilization Review Program
Assessment of Drug Utilization Patterns of Antibacterials in Ear, Nose and Throat Infections at Railway General Hospital (IIMC TRUST), Rawalpindi, Pakistan.
Dr. Sumreen Javed, Dr Aisha Khan.
Riphah Institute of Pharmaceutical Sciences, Riphah International University G-7/4 Islamabad, Pakistan.
Introduction:
Drug utilization review (DUR) is defined as the marketing, distribution, prescription, and use of medicines in a society, with special emphasis on the resulting medical, social and economic consequences [1]. DUR is an authorized and structured ongoing review of practitioner prescribing, pharmacist dispensing and patient use of medications. The purpose of DUR is to ensure drugs are used appropriately, safely and effectively to improve patient health status. (2) [3]. DUR as described by Dr. T. Donald Rucker and recommended by American medical association is that the “DUR is a formal program for assessing data on drug use against explicit, prospective standards and as necessary introducing remedial strategies to achieve some desired ends”. The three primary objectives are to improve the quality of care, to conserve program funds and individual expenditures and to maintain program integrity i.e. controlling the cases of fraud and abuse. (4)
In this study we have devised a drug utilization review program by assessing the drug utilization patterns of antibacterials use in Ear, Nose and Throat (ENT) infections in Railway General Hospital (IIMC TRUST) in our city. ENT infections deal with the infections of ear like Otitis media, otomycosis etc, the infections of nose like epistaxis, acute and chronic sinusitis, acute vestibulitis, allergic rhinitis etc and the infections of throat like sore throat, acute pharyngitis, acute and chronic tonsillitis etc. They are more common in developing countries especially in the South Asia and their mode of spread is also very fast. The primary aim of this study is to explore the anti-bacterial prescribing patterns of physicians
Dr. Sumreen Javed, Dr Aisha Khan.
Riphah Institute of Pharmaceutical Sciences, Riphah International University G-7/4 Islamabad, Pakistan.
Introduction:
Drug utilization review (DUR) is defined as the marketing, distribution, prescription, and use of medicines in a society, with special emphasis on the resulting medical, social and economic consequences [1]. DUR is an authorized and structured ongoing review of practitioner prescribing, pharmacist dispensing and patient use of medications. The purpose of DUR is to ensure drugs are used appropriately, safely and effectively to improve patient health status. (2) [3]. DUR as described by Dr. T. Donald Rucker and recommended by American medical association is that the “DUR is a formal program for assessing data on drug use against explicit, prospective standards and as necessary introducing remedial strategies to achieve some desired ends”. The three primary objectives are to improve the quality of care, to conserve program funds and individual expenditures and to maintain program integrity i.e. controlling the cases of fraud and abuse. (4)
In this study we have devised a drug utilization review program by assessing the drug utilization patterns of antibacterials use in Ear, Nose and Throat (ENT) infections in Railway General Hospital (IIMC TRUST) in our city. ENT infections deal with the infections of ear like Otitis media, otomycosis etc, the infections of nose like epistaxis, acute and chronic sinusitis, acute vestibulitis, allergic rhinitis etc and the infections of throat like sore throat, acute pharyngitis, acute and chronic tonsillitis etc. They are more common in developing countries especially in the South Asia and their mode of spread is also very fast. The primary aim of this study is to explore the anti-bacterial prescribing patterns of physicians
References: 1. Introduction to Drug Utilization Research. 2003. WHO International Working Group for Drug Statistics Methodology, WHO Collaborating Centre for Drug Statistics Methodology & WHO Collaborating Centre for Drug Utilization Research and Clinical. 3. Academy of Managed Care Pharmacy. Concept in Managed Care Pharmacy Series: Pharmaceutical Care, 2003.www.amcp.org/amcp.ark?p=AAAC630C. 5. Drug utilization pattern of antibacterials used in ear, nose and throat outpatient and inpatient departments of a university hospital at New Delhi, India, M. R. Ain, N. Shahzad et al., J Pharm Bioallied Sci. 2010 Jan-Mar; 2(1): 8–12. 6. Traditional management of ear, nose and throat (ENT) diseases in Central Kenya. Grace NN, Bussmann RW. J Ethnobiol Ethnomed. 2006; 2:54. 7 12. Upper respiratory tract infections, Jain N, Lodha R, Kabra SK. Indian J Pediatr. 2001; 68:1135–8. 13. Magic bullets, lost horizons: the rise and fall of antibiotics, Huovinen P. BMJ. 2002; 324:176–9. 14. Microbial view and optimal antibiotic therapy in acute purulent ENT diseases, Pal 'chun VT, Kunel 'skaia NL, Artem 'ev VI, Karabak VI, Ogorodnikov DS, Vestn Otorinolaringol. 2004 ;( 5):4-8. 17. A drug delivery percept and practices. Krishnaswamy K, Kumar BD, Radhaiah G. Eur J Clin Pharmacol. 1985; 29:363–70.